JAK2 and hepatocellular carcinoma: To be specific, tumor growth, M2 infiltration, and JAK2/STAT3 pathway activation induced by macrophages undergoing treatment of HCC cell‐derived exosomes were all compromised when the macrophages were treated with exosomes derived from HCC cells underexpressing PSMA5.